St. Jude ICD, Tissue Valve Differentiation Will Fall To Incoming CEO Starks
This article was originally published in The Gray Sheet
Executive Summary
Incoming Chairman and CEO Daniel Starks will direct St. Jude Medical's efforts to catch up with established players in the tissue valve and cardiac resynchronization therapy defibrillator markets
You may also be interested in...
Catheter-Based Valve Repair Technology Financed By Guidant
Guidant's foray into heart valve repair through an equity investment in Evalve could lead the larger firm into another area of competition with cardiac rhythm management firms Medtronic and St. Jude Medical
Catheter-Based Valve Repair Technology Financed By Guidant
Guidant's foray into heart valve repair through an equity investment in Evalve could lead the larger firm into another area of competition with cardiac rhythm management firms Medtronic and St. Jude Medical
People In Brief
Tunis' new deputy: CMS' Terrence Kay, hospital & ambulatory policy group deputy director, will serve a nine-month detail at the Office of Clinical Standards & Quality, effective June 14. Kay will be filling the position vacated by Robert Streimer's retirement. "It is an exciting opportunity that allows for my own professional growth, and ultimately benefits my current center/group, too, since both [the Center for Medicare Management] and OCSQ work jointly on many issues," Kay remarks. Division of Ambulatory Services Director Don Thompson will replace Kay...